Skip to main content
. 2021 Apr 27;6(18):11954–11963. doi: 10.1021/acsomega.1c00455

Table 3. In Vitro Cytotoxic Activities of p-SC6, Harmala Alkaloid-Rich Fraction, and H/p-SC6 Nanocapsules against SKOV-3, MCF-7, and Human Skin Fibroblastsa.

  in vitro cytotoxic activity (IC50 in μg/mL)
cells p-SC6 harmala alkaloid-rich fraction (positive control) H/p-SC6
SKOV-3 >300 6.7 ± 1.6 5 ± 1.3
MCF-7 >220 6.7 ± 0.7 2.3 ± 1.1
human skin fibroblasts >300 4.6 ± 1.5 >300
a

The treatment period was 48 h. Data represent the mean ± standard deviation of triplicate.